July 12, 2022
Life Sciences
  • The federal government announced that it plans to secure an initial 3.2 million doses of Novavax’s COVID-19 vaccine. If the Food and Drug Administration (FDA) grants the vaccine an Emergency Use Authorization (EUA), the government will make the vaccine available for free to states, jurisdictions, federal pharmacy partners, and federally qualified health centers. The company is expected to complete all necessary quality testing in the next few weeks, which would support final release of the product. (Press release here; Article here)